This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Mildred D. Ofosu, PhD; Oswaldo Castro, MD; Lamya Alarif, PhD

Arch Dermatol. 1987;123(4):482-484.

Abstract
• We determined the HLA-A, B, C, and DR types in nine patients with sickle cell anemia (SS) who had leg ulcers or a history of leg ulcers, and in 29 control patients with SS without leg ulcers. Six (67%) of the nine patients with leg ulcers had HLA-B35 and each of these six patients also had HLA-Cw4. In contrast, only eight (28%) of the 29 control patients with SS had HLA-B35 and only three (10%) of these patients had both HLA-B35 and Cw4. The relative risk for development of leg ulcers in patients with SS who had both HLA-B35 and Cw4 was 17 times greater than that of patients without these antigens or who had only one antigen. The frequency of HLA-B35 was also significantly higher in patients with SS and leg ulcers than in a reference population (31%) consisting of 68 healthy black persons. These results suggest that genetic factors or an HLA-related altered immune response may contribute to the development of leg ulcers in sickle cell anemia.

(Arch Dermatol 1987;123:482-484)

Author Affiliations
From the Department of Genetics and Human Genetics (Dr Ofosu) and the Center for Sickle Cell Disease and Departments of Medicine and Pediatrics (Dr Castro), Howard University College of Medicine, and the Immunogenetics Laboratory of the Research Foundation, Washington Hospital Center (Dr Alarif), Washington, DC. Dr Ofosu is now with Delaware State College, Dover.

Footnotes
Accepted for publication Nov 10, 1986.

Presented as a scientific exhibit at the 27th annual meeting of the American Society of Hematology, New Orleans, Dec 9, 1985.

Reprint requests to Howard University Center for Sickle Cell Disease, 2121 Georgia Ave NW, Washington, DC 20059 (Dr Castro).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HLA Class II Haplotypes Distinctly Associated with Vaso-Occlusion in Children with Sickle Cell Disease
Mahdi et al.
CVI 2008;15:729-731.
ABSTRACT | FULL TEXT